Change Paradigm in the Face of COVID‑19; From Bans to Incentives

Alireza Jabbari, Elaheh Mazaheri, Marziye Hadian


In December 2019, the COVID‑19 virus appeared in Wuhan, Hubei Province, in China. As of February 16, 2021, there were 109,865,149 infected people and 2,423,838 deaths due to COVID‑19 disease in the world. According to WHO, COVID‑19 disease is a common enemy of humanity and is a public health emergency. This international organization advises governments to stop the virus transmission cycle by considering proper policies.


COVID‑19; Bans; Incentives; Prevention and Control

Full Text:



Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al.

Coronavirus disease 2019 (COVID‑19): A perspective from

China. Radiology 2020;296:E15‑25.

Lupia T, Scabini S, Pinna SM, Di Perri G, De Rosa FG,

Corcione S. 2019‑novel coronavirus outbreak: A new challenge.

J Glob Antimicrob Resist 2020;21:22‑7.


2020. Available from:


Wei J, Xu H, Xiong J, Shen Q, Fan B, Ye C, et al. 2019 Novel

coronavirus (COVID‑19) pneumonia: Serial computed

tomography findings. Korean J Radiol 2020;21:501‑4.

Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD.

How will country‑based mitigation measures influence the course

of the COVID‑19 epidemic? Lancet 2020;395:931‑4.

Leung CC, Lam TH, Cheng KK. Mass masking in the COVID‑19 epidemic: People need guidance. Lancet 2020;395:945.

Prompetchara E, Ketloy C, Palaga T. Immune responses in

COVID‑19 and potential vaccines: Lessons learned from SARS

and MERS epidemic. Asian Pac J Allergy Immunol 2020;38:1‑9.

World Health Organization. Coronavirus disease (COVID‑19)

pandemic. 2020 Available from: